secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2022-07-22T23:59:59+00:00
Accession:  0001193125-22-199606
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q2 2022 net income down 20% to $1.155B; EPS $3.90 vs $4.36 YoY
-----------------------------------------------------------------------------

- Revenue $14.820B (+2.7% YoY); net income $1.155B ($3.90 EPS) vs $1.450B ($4.36) in Q2 2021.
- Adjusted EBITDA $3.042B (-5.5% YoY); same facility admissions -1.2%, equivalent admissions +0.5%.
- Operating cash flow $1.630B vs $2.251B in Q2 2021; capital expenditures $1.080B (ex-acquisitions).
- Repurchased 12.23M shares for $2.682B in Q2; $3.803B remaining under repurchase authorization.
- Board declared $0.56 quarterly dividend, payable Sept 30 to holders of record Sept 16.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312522199606/0001193125-22-199606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312522199606/d383183d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-199606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer